KR880009029A - Method for preparing pyrimido [5,4-b] [1,4] oxazine derivatives - Google Patents

Method for preparing pyrimido [5,4-b] [1,4] oxazine derivatives Download PDF

Info

Publication number
KR880009029A
KR880009029A KR870000747A KR870000747A KR880009029A KR 880009029 A KR880009029 A KR 880009029A KR 870000747 A KR870000747 A KR 870000747A KR 870000747 A KR870000747 A KR 870000747A KR 880009029 A KR880009029 A KR 880009029A
Authority
KR
South Korea
Prior art keywords
group
formula
hydrogen
compound
optionally
Prior art date
Application number
KR870000747A
Other languages
Korean (ko)
Other versions
KR900003142B1 (en
Inventor
카스즈트레이너 엔드레
라브록즈키 교기
마크 난도로
쩨흐 교기
쿠하르 네 퀴르티 마리아
디에스터 에스즈터
자스즈리츠 라스즈로
세베스티엔 라스즈로
웰만 자노스
테그데스 아니코
사로시 네 킨크세시 주디트
마티우스 페테르
바로 안드라스
스잠 라스줄로
베그바리 네 기유르키 사롤타
Original Assignee
기율라 스주크, 타마스 스주츠
치노인 교기스져 에스 베게스재티 테르메케크 기야리 알티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 기율라 스주크, 타마스 스주츠, 치노인 교기스져 에스 베게스재티 테르메케크 기야리 알티 filed Critical 기율라 스주크, 타마스 스주츠
Priority to KR1019870000747A priority Critical patent/KR900003142B1/en
Publication of KR880009029A publication Critical patent/KR880009029A/en
Application granted granted Critical
Publication of KR900003142B1 publication Critical patent/KR900003142B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음.No content.

Description

피리미도[5,4-b][1,4]옥사진 유도체의 제조방법Method for preparing pyrimido [5,4-b] [1,4] oxazine derivatives

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (1)

다음의 방법으로 다음 구조식 (I)의 신규 피리미도[5,4-b][1,4]옥사진 유도체, 그 호변이성체, 그 호변이성체 혼합물 및 그 산부가염을 제조하는 방법.A method for producing a novel pyrimido [5,4-b] [1,4] oxazine derivative of the following structural formula (I), a tautomer thereof, a tautomeric mixture thereof and an acid addition salt thereof by the following method. 식중, R1은 C1-4알킬기이고 : R2는 수소 또는 할로겐 또는 아지도기 또는 -NR5R6이고, 여기에서,5는 수소이거나 ; 벤질이거나 ; 하이드록실기로 치환되거나 또는 비치환된 C1-4알킬기이고, R6는 수소 ; 또는 아미노기 ; 또는 C3-6사이클로알킬기 ; 또는 하이드록실, 메르캅토, 아미노 카보닐, 푸릴, 2-벤조[1,4]디옥사닐 또는 디(C1-4알킬)아미노기로 임의로 치환되거나 비치환된 직쇄 또는 측쇄의 C1-4알킬기 ; 또는 할로겐 또는 C1-4알콕시기(들)로 임의로 단일 또는 다중 치환되거나 비치환된 페닐기 또는 페녹시기로 임의로 치환된 직쇄 또는 측쇄의 C1-4알킬기 ; 또는 질소 또는 산소원자를 임의로 더 함유하거나 더 함유하지 않고, C1-4알킬 또는 벤질기로 임의로 치환되거나 비치환된 질소함유 6-원 포화 헤테로사이클로 임의로 치환된 직쇄 또는 측쇄의 C1-4알킬기이거나 ; 또는 NR5R6는 임의로 질소 또는 산소원자를 더 포함하거나 더 포함하지 않고, C2-4알콕시카보닐 또는 C1-4하이드록시알킬기로 임의로 치환되거나 비치환된 질소함유 6-원 포화 헤테로사이클이고, R3및 R4는 서로 같거나 다르며, 수소 또는 C1-4알킬기이고 ; R9는 “R9가 수소일때는 R2는 염소, 4-모르폴리닐기 및 피페리딜기가 아니거나, 또는 R9가 메틸 또는 벤질기일때는 R2는 염소 및 4-모르폴리닐기가 아니다”라는 조건하에 R9는 수소이거나 ; 비치환 C1-4알킬기이거나 ; 또는 옥소, 시아노, 아미노카보닐, C2-5알콕시카보닐, 피리딜, 모르폴리노카보닐, 하이드록실 또는 페닐기로 단일 또는 다중치환된 C1-4알킬기이다.Wherein R 1 is a C 1-4 alkyl group: R 2 is hydrogen or halogen or azido or -NR 5 R 6 , wherein 5 is hydrogen; Benzyl; A C 1-4 alkyl group unsubstituted or substituted with a hydroxyl group, R 6 is hydrogen; Or amino group; Or a C 3-6 cycloalkyl group; Or a straight or branched C 1-4 alkyl group optionally substituted with a hydroxyl, mercapto, amino carbonyl, furyl, 2-benzo [1,4] dioxanyl or di (C 1-4 alkyl) amino group ; Or a straight or branched C 1-4 alkyl group optionally substituted with a single or multiple substituted or unsubstituted phenyl group or phenoxy group with halogen or C 1-4 alkoxy group (s); Or a straight or branched C 1-4 alkyl group optionally containing further nitrogen or oxygen atoms, optionally substituted with a C 1-4 alkyl or benzyl group optionally substituted with a nitrogen-containing 6-membered saturated heterocycle; ; Or NR 5 R 6 optionally further comprises no or no nitrogen or oxygen atoms and is a nitrogen-containing 6-membered saturated heterocycle optionally unsubstituted or substituted with a C 2-4 alkoxycarbonyl or C 1-4 hydroxyalkyl group. R 3 and R 4 are the same as or different from each other, and are hydrogen or a C 1-4 alkyl group; R 9 is “R 2 is not chlorine, 4-morpholinyl group and piperidyl group when R 9 is hydrogen, or R 2 is not chlorine and 4-morpholinyl group when R 9 is methyl or benzyl group” Under the condition that R 9 is hydrogen; Or an unsubstituted C 1-4 alkyl group; Or a C 1-4 alkyl group single or polysubstituted with an oxo, cyano, aminocarbonyl, C 2-5 alkoxycarbonyl, pyridyl, morpholinocarbonyl, hydroxyl or phenyl group. a) 다음 구조식 (II)의 화합물을(식중, R1,R3,R4및 R9는 구조식 (I)에 대해 전술한 바와 같고 R10은 이탈기이다).a) the compound of formula (II) Wherein R 1 , R 3 , R 4 and R 9 are as described above for formula (I) and R 10 is a leaving group. 일반식 -HNR5R6(임의로 보호기를 갖으며, R5및 R6은 구조식 (I)에 대해 전술한 바와 같다)의 아민과 반응시켜서 구조식 (I)(R2는 -NR5R6이고, 여기서 R5및 R6은 전술한 바와 같으며, R1, R3, R4및 R9는 전술한 바와 같다)의 화합물을 제조하거나 ; b) 구조식 (I)(R1,R3,R4및 R9는 구조식 (I)에 대해 전술한 바와 같으며, R2는 하이드라지노기이다)의 화합물을 디아조화시켜서 구조식 (I)(식중 R2가 아지도기이고 R1,R3,R4및 R9는 전술한 바와 같다)의 화합물을 제조하거나 ; c) 구조식 (I)(식중 R1, R2, R3및 R4는 구조식 (I)에 대해 전술한 바와 같으며, R9는 수소이다)의 화합물을 2,3-에폭시 프로판올과 반응시켜서 구조식 (I)(식중 R1,R2,R3및 R4는 전술한 바와 같으며, R9는 2,3-디하이드록시프로필기이다)의 화합물을 제조하거나 ; 전술한 공정 a) 또는 b)에서 제조한 임의로 보호기를 갖는 구조식 (I)(식중 R1,R2,R3및 R4는 구조식 (I)에 대해 전술한 바와 같으며, R9는 수소이다)의 화합물을 일반식 R9X의 화합물(임의로 보호기를 갖으며, R9는 수소를 제외하고는 구조식 (I)에 대해 전술한 바와 같으며, X는 이탈기이다)과 반응시키고 ; 및/또는 전술한 공정 a)-c) 중 어느 한 방법으로 제조한 생성물로 부터 보호기를 제거하고 ; 및/또는 전술한 방법으로 제조한 구조식 (I)의 화합물을 구조식 (I)의 다른 화합물로 전환시키고 ; 및/또는 전술한 방법으로 제조한 구조식 (I)의 염기를 산과 반응시켜서 산부가염으로 전환시키고 ; 및/또는 산부가염을 다른 종류의 산부가염으로 전환시키고 ; 및/또는 산부가염으로 부터 구조식 (I)의 염기를 유리시켜서 구조식 (I)의 화합물, 그 호변이성체, 그 호변이성체 혼합물 또는 그 산부가염을 제조하는 방법.Is reacted with an amine of the formula -HNR 5 R 6 (optionally having a protecting group, R 5 and R 6 as described above for structure (I)), wherein formula (I) (R 2 is -NR 5 R 6 Wherein R 5 and R 6 are as described above and R 1 , R 3 , R 4 and R 9 are as described above); b) diazotizing the compound of formula (I) (R 1 , R 3 , R 4 and R 9 are as described above for formula (I), and R 2 is a hydrazino group) In which R 2 is an azido group and R 1 , R 3 , R 4 and R 9 are as described above); c) reacting a compound of formula (I), wherein R 1 , R 2 , R 3 and R 4 are as described above for formula (I), wherein R 9 is hydrogen, with 2,3-epoxy propanol Preparing a compound of formula (I) wherein R 1 , R 2 , R 3 and R 4 are as defined above and R 9 is a 2,3-dihydroxypropyl group; Formula (I), optionally having a protecting group, prepared in step a) or b) above, wherein R 1 , R 2 , R 3 and R 4 are as described above for formula (I), and R 9 is hydrogen ) Is reacted with a compound of formula R 9 X (optionally having a protecting group, R 9 is as described above for formula (I) except hydrogen, X is a leaving group); And / or removing the protecting group from the product prepared by any of the processes a) -c) above; And / or converting the compound of formula (I) prepared by the above-mentioned method into another compound of formula (I); And / or the base of formula (I) prepared by the method described above is converted to an acid addition salt by reacting with an acid; And / or converting acid addition salts to other types of acid addition salts; And / or liberating the base of formula (I) from an acid addition salt to prepare a compound of formula (I), a tautomer thereof, a tautomeric mixture thereof or an acid addition salt thereof. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019870000747A 1987-01-30 1987-01-30 Process for the preparation of pyrimido (5,4b)(1,4) oxazine derivatives KR900003142B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019870000747A KR900003142B1 (en) 1987-01-30 1987-01-30 Process for the preparation of pyrimido (5,4b)(1,4) oxazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019870000747A KR900003142B1 (en) 1987-01-30 1987-01-30 Process for the preparation of pyrimido (5,4b)(1,4) oxazine derivatives

Publications (2)

Publication Number Publication Date
KR880009029A true KR880009029A (en) 1988-09-13
KR900003142B1 KR900003142B1 (en) 1990-05-09

Family

ID=19259202

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870000747A KR900003142B1 (en) 1987-01-30 1987-01-30 Process for the preparation of pyrimido (5,4b)(1,4) oxazine derivatives

Country Status (1)

Country Link
KR (1) KR900003142B1 (en)

Also Published As

Publication number Publication date
KR900003142B1 (en) 1990-05-09

Similar Documents

Publication Publication Date Title
RU1838308C (en) Method of synthesis of derivatives of substituted (1h-azole-1-ylmethyl)-benztriazole or their pharmaceutically acceptable salts of acid addition
KR850003402A (en) Method for preparing 2-amino-5-hydroxy-4-methyl pyrimidine derivative
KR870008906A (en) Method for preparing macrolide derivatives
KR890006650A (en) Tetrahydro-furo and -thieno [2,3-C] pyridine, their use as pharmaceutical preparations and methods for their preparation
ATE13056T1 (en) INDANDERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEM.
KR860009007A (en) Process for preparing piperidylidene dihydro-dibenzo [a, d] -cycloheptene
RO93855A (en) PROCESS FOR PREPARATION OF ARILCICLOBUTILALCILLAMINE
KR840006475A (en) Method for preparing naphthalene derivative
KR840003628A (en) Method for preparing pyridyl compound
KR870001199A (en) Method for preparing heterocyclic compound
KR880012532A (en) Novel bicyclic compounds, preparation methods thereof, and pharmaceutical compositions comprising the compounds
KR840006482A (en) Method for preparing [3,4-b] pyridine derivative with dihydropyrazolo
ATE18226T1 (en) PYRROLO(2,3-D)CARBAZOL DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR THERAPEUTIC USE.
KR830007655A (en) Process for preparing benzodiazepine compound
KR880009029A (en) Method for preparing pyrimido [5,4-b] [1,4] oxazine derivatives
ES8801637A1 (en) Derivatives of 2-fluoroalkylbenzimidazole, process for their preparation and pharmaceutical compositions containing them.
KR870006059A (en) 6H-isoxazolo [5,4-d] pyrazolo [3,4-b] pyridine and preparation method thereof
JPS51118772A (en) Method for preparing carbostyryl derivatives
KR870004038A (en) Method for preparing herbicide compound
KR840001154A (en) Method for preparing 1,2-dithiol-3-ylidene ammonium derivative
ES8406457A1 (en) Piperazine derivatives
KR910004632A (en) Novel 1-oxa-2-oxo-8-azaspiro [4,5] decane derivatives, pharmaceutical compositions comprising them and methods for preparing the same
KR860004040A (en) Method for preparing 3,4-diazole derivative
JPS52116497A (en) Fused-ring triazolopyrimidine derivatives
GB1418831A (en) Reserpine derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19930507

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee